Sarah Gooding
University of Oxford
H-index: 14
Europe-United Kingdom
Top articles of Sarah Gooding
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Determinants of durable humoral and T cell immunity in myeloma patients following COVID‐19 vaccination | European Journal of Haematology | Clement Twumasi Sally Moore Ross Sadler Sally Jeans Sherin Varghese | 2024/4 |
P1362: DEVELOPMENT OF A NOVEL ONCOLYTIC VIRUS-THEO-310-SPECIALISED FOR TARGETING THE BONE MARROW TUMOUR MICROENVIRONMENT OF MULTIPLE MYELOMA PATIENTS | HemaSphere | Rebecca Bamford Shayda Maleki-Toyserkani Will Taverner Josh Freedman Matt Hayman | 2023/8/1 |
High Throughput Risk-Adapted Monoclonal Gammopathy Community Monitoring Program | Blood | Gaurav Agarwal Lauren Campbell Oluremi Carty Sally Moore Sarah Gooding | 2023/11/28 |
Whole-genome analysis identifies novel drivers and high-risk double-hit events in relapsed/refractory myeloma | Blood | Naser Ansari-Pour Mehmet Samur Erin Flynt Sarah Gooding Fadi Towfic | 2023/2/9 |
High Success Rates Utilizing Local Standard of Care Cytogenetic Testing for Risk Stratified Frontline Therapy for Newly Diagnosed Multiple Myeloma: Experience from the Ukmra … | Blood | Dipal Mehta Laura Chiecchio Martin F Kaiser Sarah Gooding Kara-Louise Royle | 2023/11/28 |
Human bone marrow organoids for disease modeling, discovery, and validation of therapeutic targets in hematologic malignancies | Cancer discovery | Abdullah O Khan Antonio Rodriguez-Romera Jasmeet S Reyat Aude-Anais Olijnik Michela Colombo | 2023/2/6 |
P-381 Mezigdomide (CC-92480) activates innate and adaptive immune populations in the bone marrow microenvironment of heavily pre-treated multiple myeloma patients | Clinical Lymphoma Myeloma and Leukemia | Lucia Chen Michael Amatangelo Oliver van Oekelen Bhaskar Upadhyaya Alessandro Lagana | 2023/9/1 |
Targeted NGS Panel Guides Risk-Adapted Treatment Intention in Newly Diagnosed Myeloma Patients | Blood | Gaurav Agarwal Mohammad Kazeroun Mirian Salazar Khrystal McBean Lisa Ferguson | 2023/11/28 |
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma | Blood cancer journal | Keiji Kurata Anna James-Bott Mark A Tye Leona Yamamoto Mehmet K Samur | 2023/1/12 |
P-378 Longitudinal antibody and T-cell kinetics over four doses of COVID-19 vaccination and predictors of poor response in patients with multiple myeloma | Clinical Lymphoma Myeloma and Leukemia | Gaurav Agarwal Sally Moore Ross Sadler Sherin Varghese Alison Turner | 2023/9/1 |
Acquisition of 1pLOH-1qGain Is a Frequent Trajectory in Expanding Relapsed/Refractory Myeloma Subclones | Blood | Naser Ansari-Pour Mohammad Kazeroun Evie Fitzsimons Selina J Chavda Alessandro Lagana | 2023/11/28 |
P-088 High throughput MGUS monitoring program to support incidental MGUS (iMGUS) detection in the community | Clinical Lymphoma Myeloma and Leukemia | Gaurav Agarwal Lauren Campbell Oluremi Carty Sally Moore Sarah Gooding | 2023/9/1 |
Mezigdomide Treatment in Relapsed-Refractory Myeloma Patients Shifts Bone Marrow NK and T Cell Populations from Exhaustion to Activation | Blood | Lucia Y Chen Oliver Van Oekelen Michael Amatangelo Tracy T Chow Bhaskar Upadhyaya | 2023/11/28 |
Anti-BCMA Immunotherapy in Myeloma: Is It the Tumor or the Immune System That Most Undermines Outcomes? | The Hematologist | Edmund Watson Sarah Gooding Karthik Ramasamy | 2022/5/1 |
COVID symptoms, testing, shielding impact on patient‐reported outcomes and early vaccine responses in individuals with multiple myeloma | British Journal of Haematology | Karthik Ramasamy Ross Sadler Sally Jeans Sherin Varghese Alison Turner | 2022/1 |
P-043: Prospective assessment of myeloma tumour burden and bone disease using DW-MRI and exploratory bone biomarkers | Clinical Lymphoma Myeloma and Leukemia | Gaurav Agarwal Guido Nador Sherin Varghese Hiwot Getu Charlotte Palmer | 2022/8/1 |
Artificial Intelligence-Based Quantitative and Topological Analysis of Plasma Cell Burden: A New Tool for the Assessment of Myeloma | Blood | Oliver C Lomas Daniel Royston Hosuk Ryou Alan Aberdeen Korsuk Sirinukunwattana | 2022/11/15 |
Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple Myeloma | Transplantation and cellular therapy | Sarah A Holstein Fotis Asimakopoulos Abdel Kareem Azab Giada Bianchi Manisha Bhutani | 2022/8/1 |
Tumor and microenvironmental mechanisms of resistance to immunomodulatory drugs in multiple myeloma | Lucia Y Chen Sarah Gooding | 2022/11/9 | |
Immune response to COVID‐19 vaccination is attenuated by poor disease control and antimyeloma therapy with vaccine driven divergent T‐cell response | British Journal of Haematology | Karthik Ramasamy Ross Sadler Sally Jeans Paul Weeden Sherin Varghese | 2022/5 |
